By Chelsea Naso ( May 13, 2015, 7:18 PM EDT) -- Venture capital-backed glaucoma treatment maker Glaukos Corp. joined the initial public offering pipeline on Tuesday, marking the second life sciences company to file its plans this week despite a recent flurry of IPO postponements and disappointing pricings....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.